Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M8KC
|
|||
Drug Name |
PMID25522065-Compound-48
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H22ClNO5
|
|||
Canonical SMILES |
CC(C)(COC1=C(C=C(C=C1)N2C=CC3=C(C2=O)C=C(O3)C4=CC=C(C=C4)Cl)OC)O
|
|||
InChI |
1S/C24H22ClNO5/c1-24(2,28)14-30-20-9-8-17(12-22(20)29-3)26-11-10-19-18(23(26)27)13-21(31-19)15-4-6-16(25)7-5-15/h4-13,28H,14H2,1-3H3
|
|||
InChIKey |
UBVMNCOEYQICSI-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Melanin-concentrating hormone receptor 1 (MCHR1) | Target Info | Antagonist | [1] |
Target's Patent Info | Melanin-concentrating hormone receptor 1 (MCHR1) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.